Rapidly growing pharmaceutical services platform continues to expand team with experienced business development executive.
, /PRNewswire/ — Petauri, a leading purpose-built pharmaceutical services platform, today announced the appointment of Mark Levonyak as Executive Vice President of New Business for Petauri Advance, the organization’s scientific and medical communications business unit. In this role, Mark will lead the strategic direction and growth of new business activities, while also commercializing existing and new products and services.
Mark’s extensive background includes 39 years of dedicated service in drug development, clinical operations, medical affairs, and commercialization activities across medical communications, pharmaceutical, and biotech companies. Most recently, Mark served as Executive Vice President and Executive Clinical Strategist at Vaniam Group, LLC, where he was instrumental in developing and managing multiple business units. Mark’s career highlights also include his tenure as President at DAVA Oncology, LLC along with C-suite commercial roles at AnorMED and Cell Therapeutics.
“We are thrilled to welcome Mark Levonyak to Petauri,” said Dan Renick, CEO, Petauri. …